Countries Europe

Aptamer launches Optimer®-Fc as a new reagent solution for immunohistochemistry

Two top 10 pharma companies are seeking to trial Optimer-Fc for IHC Aptamer is currently working with one of the top three IHC companies to validate the...

 March 21, 2023 | News

Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution

Lunit set to launch Lunit INSIGHT DBT in the European market Lunit seeks FDA clearance, paving the way into the US market The MDR CE certification is...

 March 21, 2023 | News

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

 BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

 March 20, 2023 | News

Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease

Huntington's disease is a debilitating genetic disorder that affects the brain, causing gradual degeneration of nerve cells in specific areas of the brain,...

 March 20, 2023 | News

Servier partners with QIAGEN for mIDH1 Diagnostic Test

Servier, a global pharmaceutical group, today announced it has entered into a strategic partnership with QIAGEN, a leading global provider of Sample to Ins...

 March 09, 2023 | News

Alnylam and Medison Pharma expand RNAi Therapeutics Partnership

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma co...

 March 09, 2023 | News

IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker®...

 March 09, 2023 | News

Virax Biolabs Introduces Avian Influenza PCR Test Kit

The test kit is for use in laboratory settings and can help healthcare professionals accurately identify an AIV infection. It also serves as a valuable ini...

 March 09, 2023 | News

MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules

“We are thrilled to offer this cutting-edge technology to the research community,” says Jos Joore, co-CEO of MIMETAS. “We&rsquo...

 March 08, 2023 | News

Abacus Medicine Pharma Services and AddMedica Sign Partnership Agreement for the Distribution of Siklos® in Benelux

Simon Estcourt, Managing Director of Abacus Medicine Pharma Services explains: “This partnership agreement between Abacus Medicine Pharma Servic...

 March 07, 2023 | News

Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance

 Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published the findings of an...

 March 07, 2023 | News

Hummingbird Bioscience licenses Cancer Research UK's clinical trial results to support HMBD-001 development.

The Phase 1/2a clinical trial in the United Kingdom is being sponsored and managed by CRUK's Centre for Drug Development and led by Chief Investi...

 March 06, 2023 | News

Harbour BioMed's Batoclimab Shows Positive Results in Phase III Trial for Myasthenia Gravis

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ant...

 March 06, 2023 | News

Prenetics Forms Advisory Board for Precision Oncology Strategy

Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Adviso...

 March 02, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close